Abstract:Under new U.S. Department of Health and Human Services rules, hospitals must post prices for all of their services as of 1 January 2019. This federal mandate is just the latest government foray in price transparency. More than one half of states has passed some form of price transparency legislation (1). The growing bipartisan demand for price transparency taps into frustration with high health care prices in the United States, the confusing way prices are communicated, and exorbitant "surprise bills" when a patient inadvertently sees an out-of-network provider. One hope is that communicating prices will cause patients to shop for lower ones, putting downward pressure on price growth.Under new U.S. Department of Health and Human Services rules, hospitals must post prices for all of their services as of 1 January 2019. This federal mandate is just the latest government foray in price transparency. More than one half of states has passed some form of price transparency legislation (1). The growing bipartisan demand for price transparency taps into frustration with high health care prices in the United States, the confusing way prices are communicated, and exorbitant "surprise bills" when a patient inadvertently sees an out-of-network provider. One hope is that communicating prices will cause patients to shop for lower ones, putting downward pressure on price growth.Are transparency efforts working, and will the Trump administration's new hospital price disclosure rule help? In a word, no. However, this problem has more to do with how these efforts are being implemented than with the idea of price transparency itself. The new rule mandates that hospitals report their chargemaster prices, but a vast gulf unfortunately remains between these prices and what insurers or patients actually pay. On average, Medicare pays 31% of charges (2). Furthermore, patients do not care what insurers pay—they care about their out-of-pocket payment based on their insurance benefit design.Are transparency efforts working, and will the Trump administration's new hospital price disclosure rule help? In a word, no. However, this problem has more to do with how these efforts are being implemented than with the idea of price transparency itself. The new rule mandates that hospitals report their chargemaster prices, but a vast gulf unfortunately remains between these prices and what insurers or patients actually pay. On average, Medicare pays 31% of charges (2). Furthermore, patients do not care what insurers pay—they care about their out-of-pocket payment based on their insurance benefit design.Another problem with chargemaster price disclosure is that it takes place at the individual service and supply level. Even if patients were motivated to shop for the lowest price, they typically would not shop separately for each bandage, scan, or laboratory test. These costs...Another problem with chargemaster price disclosure is that it takes place at the individual service and supply level. Even if patients were motivated to shop for the lowest price, they typically would not shop separately for each bandage, scan, or laboratory test. These costs...

The Evolution and Impact of Hospital Price Transparency in North Carolina

Taking the Pulse of Hospitals’ Response to the New Price Transparency Rule

What Type of Price Transparency Do We Need in Health Care?

The Accuracy of Price Transparency Files at Top-Rated US Hospitals

Impacts of Health Information Technologies on E-Quality and E-Revenue Hospitals

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US

Trends in hospital price transparency after implementation of the CMS Final Rule

114 Compliance with Federal Price Transparency Rules at US Hospitals With Neurosurgical Training Programs

REPORTED PRICES FOR HIGH VOLUME HAND SURGERY IN THE ERA OF PRICE TRANSPARENCY: IMPLICATIONS FOR FUTURE POLICY ITERATIONS

Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation

The Revival of US Hospital Care, 2004–2019

Price Transparency in United States' Health Care: A Narrative Policy Review of the Current State and Way Forward

Variation in Commercial Prices for Thyroidectomy and Parathyroidectomy at US Hospitals

Does Information Disclosure among Public Hospitals Stimulate Medical Cost Change Efforts? A Pilot Study in Shanghai

Cross-validation of insurer and hospital price transparency data

Physician Response to Prices of Other Physicians: Evidence from a Field Experiment

S2156 Credit or Debit? Comparison of Upper Midwest Common Gastroenterology Procedures

Price Transparency For Medical Devices

The Controversy over Price Transparency: Patients and Plastic Surgeons Disagree

Impacts of Price Changes on Public Hospital Reforms in China: Evidence from 25 Million Patients at Tertiary Hospitals.

The relationship between community social risk factors and regional hospital-reported cash, negotiated, and chargemaster prices for 14 common services